✦ LIBER ✦

PS13 Late breaking Paclitaxel poliglumex vs. docetaxel for the second-line treatment of non-small cell lung cancer (NSCLC): the STELLAR 2 phase III study

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase III trial comparing paclitaxel pol

✍ Paz-Ares, L; Ross, H; O'Brien, M; Riviere, A; Gatzemeier, U; Von Pawel, J; Kauke 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 143 KB

O-099 XYOTAX™ vs. docetaxel for the seco

✍ Bonomi, P.; Paz-Ares, L.; Langer, C.; O'Brien, M.; Gervais, R.; Gatzemeier, U.; 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 131 KB

1122 ORAL Paclitaxel poliglumex vs. gemc

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 149 KB

O-101 XYOTAX™/carboplatin vs paclitaxel/

✍ Langer, C.; O'Byrne, K.; Ross, H.; Socinski, M.; Szczesna, A.; Dediu, M.; Orlov, 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 136 KB

6615 POSTER Biweekly paclitaxel as secon

✍ Vázquez-Estévez, S.; Fírvida, J.L.; Grande, C.; Barón, F.; Lázaro, M.; Salgado, 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 58 KB

O-104 XYOTAXT™ vs. gemcitabine or vinore

✍ O'Brien, M.; Sandler, A.; Popovich, A.; Ganchev, H.; Bogdanova, N.; Miziara, J. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 143 KB